Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification.
- 1 January 1998
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 36 (2) , 149-157
- https://doi.org/10.1023/a:1005819604858
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Mitochondria‐bound hexokinase as target for therapy of malignant gliomasInternational Journal of Cancer, 1995
- Rapid Purification of Mitochondrial Hexokinase from Rat Brain by a Single Affinity Chromatography Step on Affi-Gel BluePreparative Biochemistry, 1989
- Modulation of adriamycin uptake by lonidamine in ehrlich ascites tumor cellsExperimental and Molecular Pathology, 1988
- Phosphate metabolites in rat skinNMR in Biomedicine, 1988
- Differential effect of Lonidamine on the plasma membrane ultrastructure of normal and leukemic human lymphocytesExperimental and Molecular Pathology, 1988
- Radiosensitization of Meth-A Fibrosarcoma in Mice by LonidamineOncology, 1984
- Issues in the in vivo measurement of glucose metabolism of human central nervous system tumorsAnnals of Neurology, 1984
- Lonidamine: A Hyperthermic Sensitizer of HeLa Cells in Culture and of the Meth-A Tumor in vivoOncology, 1984
- Effects of Lonidamine on Murine and Human Tumor Cells in vitroOncology, 1984
- In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomasAnnals of Neurology, 1983